Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 55, Issue 2, Pages (August 2011)

Similar presentations


Presentation on theme: "Volume 55, Issue 2, Pages (August 2011)"— Presentation transcript:

1 Volume 55, Issue 2, Pages 491-496 (August 2011)
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation?  Salvatore Piano, Filippo Morando, Silvano Fasolato, Marta Cavallin, Novella Boscato, Patrizia Boccagni, Giacomo Zanus, Umberto Cillo, Angelo Gatta, Paolo Angeli  Journal of Hepatology  Volume 55, Issue 2, Pages (August 2011) DOI: /j.jhep Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

2 Fig. 1 Time course of serum creatinine and treatment with terlipressin and albumin in patient 1. The daily dose of terlipressin is also indicated. Albumin was administered at the dose of 20–40g/day for the duration of treatment with terlipressin. Dotted line indicates a 133μmol/L value of serum creatinine. Dashed line indicates a 226μmol/l value of serum creatinine. Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

3 Fig. 2 Model of End Stage Liver Disease (MELD) score, Na-MELD. ‘Actual’ values were calculated on the basis of the serum creatinine value during treatment. ‘Real’ values were calculated on the basis of the peak value of serum creatinine during the last episode of type 1 HRS. Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

4 Fig. 3 Time course of glomerular filtration rate calculated on the basis of the Modification of Diet in Renal Disease (MDRD) equation after LT in the three patients. Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

5 Fig. 4 Time course of serum creatinine and treatment with terlipressin and albumin in patient 2. The daily dose of terlipressin is also indicated. Albumin was administered at the dose of 20–40g/day for the duration of treatment with terlipressin. Dotted line indicates a 133μmol/L value of serum creatinine. Dashed line indicates a 226μmol/L value of serum creatinine. Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

6 Fig. 5 Time course of serum creatinine and treatment with terlipressin and albumin in patient 3. The dose of terlipressin is also indicated. Albumin was administered at the dose of 20–40g/day for the duration of treatment with terlipressin. Dotted line indicates a 133μmol/L value of serum creatinine. Dashed line indicates a 226μmol/L value of serum creatinine. Journal of Hepatology  , DOI: ( /j.jhep ) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions


Download ppt "Volume 55, Issue 2, Pages (August 2011)"

Similar presentations


Ads by Google